| LegalShield | 65.9 | 3 | 1 |
| CMS | 65.9 | 3 | 1 |
| Deloitte | 60.0 | 4 | 0 |
| Thomson Reuters | 60.0 | 4 | 0 |
| Westlaw | 60.0 | 4 | 0 |
| ContractSafe | 60.0 | 4 | 0 |
| PricewaterhouseCoopers | 51.7 | 3 | 0 |
| Ogletree Deakins | 51.7 | 3 | 0 |
| Watchkeeper WK450 | 41.0 | 2 | 0 |
| Wolters Kluwer | 41.0 | 2 | 0 |
| Ernst & Young | 41.0 | 2 | 0 |
| KPMG | 41.0 | 2 | 0 |
| LexisNexis | 41.0 | 2 | 0 |
| Hogan Lovells | 41.0 | 2 | 0 |
| Pinsent Masons | 41.0 | 2 | 0 |
| Skadden, Arps, Slate, Meagher & Flom | 41.0 | 2 | 0 |
| White & Case | 41.0 | 2 | 0 |
| Shearman & Sterling | 41.0 | 2 | 0 |
| Wolters Kluwer Deutschland | 41.0 | 2 | 0 |
| CartaX | 41.0 | 2 | 0 |
| Corporation Service Company | 41.0 | 2 | 0 |
| Norton Rose Fulbright | 41.0 | 2 | 0 |
| ACS Award in Surface Chemistry | 41.0 | 2 | 0 |
| Sidley Austin | 41.0 | 2 | 0 |
| E. Bright Wilson Award in Spectroscopy | 41.0 | 2 | 0 |
| The Morning Call | 41.0 | 2 | 0 |
| Baker Botts | 41.0 | 2 | 0 |
| Bryan Cave | 41.0 | 2 | 0 |
| Gowlings | 41.0 | 2 | 0 |
| Holman Fenwick Willan | 41.0 | 2 | 0 |
| Lawyers on Demand | 41.0 | 2 | 0 |
| Littler Mendelson | 41.0 | 2 | 0 |
| Mayer Brown | 41.0 | 2 | 0 |
| Quarles & Brady | 41.0 | 2 | 0 |
| RingCentral | 41.0 | 2 | 0 |
| Simmons & Simmons | 41.0 | 2 | 0 |
| Travers Smith | 41.0 | 2 | 0 |
| Wilson Elser Moskowitz Edelman & Dicker | 41.0 | 2 | 0 |
| Deloitte Deutschland | 41.0 | 2 | 0 |
| Reuters 3000 Xtra | 41.0 | 2 | 0 |
| Vistra | 41.0 | 2 | 0 |
| Forbes 30 Under 30 | 41.0 | 2 | 0 |
| ACS Award in Analytical Chemistry | 41.0 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 41.0 | 2 | 0 |
| Elias James Corey Award | 41.0 | 2 | 0 |
| bidirectional encoder representations from transformers | 41.0 | 2 | 0 |
| OneTrust | 41.0 | 2 | 0 |
| Aon Jauch & Hübener Gesellschaft m.b.H. | 41.0 | 2 | 0 |
| Mitratech | 41.0 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 41.0 | 2 | 0 |
| Forbes ASAP | 41.0 | 2 | 0 |
| Alfred Bader Award in Bioinorganic or Bioorganic Chemistry | 41.0 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 41.0 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 41.0 | 2 | 0 |
| Jordan/Zalaznick Advisers Inc. | 41.0 | 2 | 0 |
| Waystone Compliance Solutions | 41.0 | 2 | 0 |
| Mindcrest | 40.1 | 1 | 1 |
| Integreon, Inc. | 40.1 | 1 | 1 |
| Royal Bank of Canada | 40.0 | 0 | 6 |
| The Hollywood Reporter | 25.8 | 1 | 0 |
| arXiv | 25.8 | 1 | 0 |
| American Chemical Society | 25.8 | 1 | 0 |
| McKinsey & Company | 25.8 | 1 | 0 |
| Accenture | 25.8 | 1 | 0 |
| Accolade | 25.8 | 1 | 0 |
| Deloitte Football Money League | 25.8 | 1 | 0 |
| FTSE 100 Index | 25.8 | 1 | 0 |
| The World's Billionaires | 25.8 | 1 | 0 |
| Andrew Corporation | 25.8 | 1 | 0 |
| Q636192 | 25.8 | 1 | 0 |
| Evalueserve | 25.8 | 1 | 0 |
| Arts and Humanities Citation Index | 25.8 | 1 | 0 |
| Q735991 | 25.8 | 1 | 0 |
| Aon plc | 25.8 | 1 | 0 |
| International Bar Association | 25.8 | 1 | 0 |
| Baker McKenzie | 25.8 | 1 | 0 |
| Game Developer | 25.8 | 1 | 0 |
| Irving Langmuir Award in Chemical Physics | 25.8 | 1 | 0 |
| Peter Debye Award in Physical Chemistry | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| The World's Most Powerful People | 25.8 | 1 | 0 |
| Taylor Wessing | 25.8 | 1 | 0 |
| Freshfields Bruckhaus Deringer | 25.8 | 1 | 0 |
| Clifford Chance | 25.8 | 1 | 0 |
| Cognizant Technology Solutions | 25.8 | 1 | 0 |
| Forbes Global 2000 | 25.8 | 1 | 0 |
| DLA Piper | 25.8 | 1 | 0 |
| Thales Group | 25.8 | 1 | 0 |
| Ernest Guenther Award | 25.8 | 1 | 0 |
| Ebony | 25.8 | 1 | 0 |
| Entrepreneur of the Year | 25.8 | 1 | 0 |
| Wipro | 25.8 | 1 | 0 |
| Mike Lazaridis | 25.8 | 1 | 0 |
| Morningstar, Inc. | 25.8 | 1 | 0 |
| The Buffalo News | 25.8 | 1 | 0 |
| The Thomson Corporation | 25.8 | 1 | 0 |
| TMF Group | 25.8 | 1 | 0 |
| Essence | 25.8 | 1 | 0 |
| Kroll Inc. | 25.8 | 1 | 0 |
| Kentico | 25.8 | 1 | 0 |
| McKinsey Quarterly | 25.8 | 1 | 0 |
| Garvan–Olin Medal | 25.8 | 1 | 0 |
| Osborne Clarke | 25.8 | 1 | 0 |
| Q2077283 | 25.8 | 1 | 0 |
| Allen & Overy | 25.8 | 1 | 0 |
| Ralph F. Hirschmann Award in Peptide Chemistry | 25.8 | 1 | 0 |
| Thales Avionics | 25.8 | 1 | 0 |
| Forbes 400 | 25.8 | 1 | 0 |
| The Denver Post | 25.8 | 1 | 0 |
| Journal Citation Reports | 25.8 | 1 | 0 |
| Bubsy 3D | 25.8 | 1 | 0 |
| Pittsburgh Post-Gazette | 25.8 | 1 | 0 |
| Teopad | 25.8 | 1 | 0 |
| Thales Australia | 25.8 | 1 | 0 |
| Thales Defense & Security | 25.8 | 1 | 0 |
| The Columbus Dispatch | 25.8 | 1 | 0 |
| SAMP/T | 25.8 | 1 | 0 |
| Manatt, Phelps & Phillips | 25.8 | 1 | 0 |
| Thales Nederland | 25.8 | 1 | 0 |
| Accounting Today | 25.8 | 1 | 0 |
| AlixPartners | 25.8 | 1 | 0 |
| Annotated Code of Maryland | 25.8 | 1 | 0 |
| Authors' Licensing and Collecting Society | 25.8 | 1 | 0 |
| BDO Seidman | 25.8 | 1 | 0 |
| Bangor Daily News | 25.8 | 1 | 0 |
| Browne Jacobson | 25.8 | 1 | 0 |
| CPA Practice Advisor | 25.8 | 1 | 0 |
| CT | 25.8 | 1 | 0 |
| Christopher Wolf | 25.8 | 1 | 0 |
| CommScope | 25.8 | 1 | 0 |
| Control Engineering | 25.8 | 1 | 0 |
| Crain's Chicago Business | 25.8 | 1 | 0 |
| Daniel Bernard Levin | 25.8 | 1 | 0 |
| Denver University Law Review | 25.8 | 1 | 0 |
| EXL | 25.8 | 1 | 0 |
| Ebiquity | 25.8 | 1 | 0 |
| Editor & Publisher | 25.8 | 1 | 0 |
| Engineering News-Record | 25.8 | 1 | 0 |
| Fennemore Craig | 25.8 | 1 | 0 |
| Foodservice Equipment & Supplies | 25.8 | 1 | 0 |
| Foster Natural Gas/Oil Report | 25.8 | 1 | 0 |
| Fulbright & Jaworski | 25.8 | 1 | 0 |
| Georgetown International Environmental Law Review | 25.8 | 1 | 0 |
| Georgetown Law Journal | 25.8 | 1 | 0 |
| Gibson, Dunn & Crutcher | 25.8 | 1 | 0 |
| London Stock Exchange Group | 25.8 | 1 | 0 |
| Grant Thornton LLP | 25.8 | 1 | 0 |
| Harney Westwood & Riegels | 25.8 | 1 | 0 |
| Harvard International Law Journal | 25.8 | 1 | 0 |
| Harvard Journal on Legislation | 25.8 | 1 | 0 |
| Hastings International and Comparative Law Review | 25.8 | 1 | 0 |
| Hinshaw & Culbertson LLP | 25.8 | 1 | 0 |
| Hunton Andrews Kurth | 25.8 | 1 | 0 |
| K&L Gates | 25.8 | 1 | 0 |
| LegalZoom | 25.8 | 1 | 0 |
| Lowenstein Sandler | 25.8 | 1 | 0 |
| OUT-LAW | 25.8 | 1 | 0 |
| Osler, Hoskin & Harcourt | 25.8 | 1 | 0 |
| Pangea3 | 25.8 | 1 | 0 |
| Pepper Hamilton | 25.8 | 1 | 0 |
| QualitySolicitors | 25.8 | 1 | 0 |
| Quinn Emanuel Urquhart & Sullivan | 25.8 | 1 | 0 |
| Ropes & Gray | 25.8 | 1 | 0 |
| Simpson Thacher & Bartlett | 25.8 | 1 | 0 |
| Slaughter and May | 25.8 | 1 | 0 |
| Stripe | 25.8 | 1 | 0 |
| TCS BaNCS | 25.8 | 1 | 0 |
| Taft Stettinius & Hollister | 25.8 | 1 | 0 |
| Thales Optronics | 25.8 | 1 | 0 |
| Thales Rail Signalling Solutions | 25.8 | 1 | 0 |
| Thales Training & Simulation | 25.8 | 1 | 0 |
| The Fresno Bee | 25.8 | 1 | 0 |
| The Hill | 25.8 | 1 | 0 |
| The Law Society Gazette | 25.8 | 1 | 0 |
| The Pantagraph | 25.8 | 1 | 0 |
| The Taos News | 25.8 | 1 | 0 |
| Tri-Valley Herald | 25.8 | 1 | 0 |
| Vorys, Sater, Seymour and Pease | 25.8 | 1 | 0 |
| Williams Lea | 25.8 | 1 | 0 |
| Wyoming Tribune Eagle | 25.8 | 1 | 0 |
| PricewaterhouseCoopers Japan LLC | 25.8 | 1 | 0 |
| Tata Consultancy Services Japan | 25.8 | 1 | 0 |
| Accenture Technology Solutions Japan | 25.8 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 25.8 | 1 | 0 |
| Deloitte Tohmatsu | 25.8 | 1 | 0 |
| Q11375641 | 25.8 | 1 | 0 |
| KPMG Azsa LLC | 25.8 | 1 | 0 |
| Deloitte Touche Tohmatsu LLC | 25.8 | 1 | 0 |
| Tata Consultancy Services | 25.8 | 1 | 0 |
| Financial Stability Board | 25.8 | 1 | 0 |
| Dentons | 25.8 | 1 | 0 |
| MTI Consulting | 25.8 | 1 | 0 |
| Herbert Smith Freehills | 25.8 | 1 | 0 |
| Thales Microelectronics | 25.8 | 1 | 0 |
| Hotels (magazine) | 25.8 | 1 | 0 |
| Q15373669 | 25.8 | 1 | 0 |
| American Review of International Arbitration | 25.8 | 1 | 0 |
| American Criminal Law Review | 25.8 | 1 | 0 |
| California Western International Law Journal | 25.8 | 1 | 0 |
| Current Opinion in Molecular Therapeutics | 25.8 | 1 | 0 |
| Duke Environmental Law and Policy Forum | 25.8 | 1 | 0 |
| Acta Neurologica Taiwanica | 25.8 | 1 | 0 |
| Energy Law Journal | 25.8 | 1 | 0 |
| Employee Rights and Employment Policy Journal | 25.8 | 1 | 0 |
| Journal of Law and Policy | 25.8 | 1 | 0 |
| DePaul Journal of Art and Entertainment Law | 25.8 | 1 | 0 |
| Harvard Environmental Law Review | 25.8 | 1 | 0 |
| University of Hawaii Law Review | 25.8 | 1 | 0 |
| Connecticut Insurance Law Journal | 25.8 | 1 | 0 |
| Journal of Energy and Natural Resources Law | 25.8 | 1 | 0 |
| Harvard Human Rights Journal | 25.8 | 1 | 0 |
| Politics and Culture | 25.8 | 1 | 0 |
| ACS Award for Creative Work in Synthetic Organic Chemistry, | 25.8 | 1 | 0 |
| American Chemical Society Award in Inorganic Chemistry | 25.8 | 1 | 0 |
| American Chemical Society Award in Organometallic Chemistry | 25.8 | 1 | 0 |
| ACS Award in Theoretical Chemistry | 25.8 | 1 | 0 |
| Hastings Law Journal | 25.8 | 1 | 0 |
| E. V. Murphree Award in Industrial and Engineering Chemistry | 25.8 | 1 | 0 |
| George A. Olah Award in Hydrocarbon or Petroleum Chemistry | 25.8 | 1 | 0 |
| Roger Adams Award in Organic Chemistry | 25.8 | 1 | 0 |
| Mohamed Mansour | 25.8 | 1 | 0 |
| Litéra | 25.8 | 1 | 0 |
| Furniture Today | 25.8 | 1 | 0 |
| Mitchell & Titus | 25.8 | 1 | 0 |
| Hewitt Associates | 25.8 | 1 | 0 |
| Polsinelli | 25.8 | 1 | 0 |
| Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo | 25.8 | 1 | 0 |
| National Equality Standard | 25.8 | 1 | 0 |
| HotDocs | 25.8 | 1 | 0 |
| Q17192764 | 25.8 | 1 | 0 |
| Deloitte Netherlands | 25.8 | 1 | 0 |
| Kennedy Wilson Europe Real Estate | 25.8 | 1 | 0 |
| EY Sweden | 25.8 | 1 | 0 |
| Matthew Bender & Co. | 25.8 | 1 | 0 |
| Food and drug law journal | 25.8 | 1 | 0 |
| Kennedys Law | 25.8 | 1 | 0 |
| legal.io | 25.8 | 1 | 0 |
| Thales Italia Chieti Site | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| Holmes | 25.8 | 1 | 0 |
| Heroes of Chemistry | 25.8 | 1 | 0 |
| Firehouse | 25.8 | 1 | 0 |
| Compliance magazine | 25.8 | 1 | 0 |
| Convenience Store News | 25.8 | 1 | 0 |
| Diagnostic imaging | 25.8 | 1 | 0 |
| Health law vigil | 25.8 | 1 | 0 |
| The Medico-legal journal | 25.8 | 1 | 0 |
| Health management technology | 25.8 | 1 | 0 |
| Hepatitis Weekly | 25.8 | 1 | 0 |
| AIDS weekly | 25.8 | 1 | 0 |
| International journal of women's dermatology | 25.8 | 1 | 0 |
| Wolters Kluwer Health | 25.8 | 1 | 0 |
| ACS Award for Encouraging Underrepresented and Economically Disadvantaged Students into Careers in the Chemical Sciences | 25.8 | 1 | 0 |
| Cognia | 25.8 | 1 | 0 |
| Conduent | 25.8 | 1 | 0 |
| Cognizant (India) | 25.8 | 1 | 0 |
| Thales | 25.8 | 1 | 0 |
| Thales Group (Germany) | 25.8 | 1 | 0 |
| Thales (Portugal) | 25.8 | 1 | 0 |
| Wipro (Singapore) | 25.8 | 1 | 0 |
| Accenture (Spain) | 25.8 | 1 | 0 |
| Accenture (United States) | 25.8 | 1 | 0 |
| Ernst and Young Foundation | 25.8 | 1 | 0 |
| QuintilesIMS (United Kingdom) | 25.8 | 1 | 0 |
| Cognizant (United Kingdom) | 25.8 | 1 | 0 |
| Thales | 25.8 | 1 | 0 |
| Thales | 25.8 | 1 | 0 |
| Thales Group (Brazil) | 25.8 | 1 | 0 |
| Thales (Norway) | 25.8 | 1 | 0 |
| Accenture (Norway) | 25.8 | 1 | 0 |
| Accenture (United Kingdom) | 25.8 | 1 | 0 |
| Accenture (Switzerland) | 25.8 | 1 | 0 |
| Accenture (Sweden) | 25.8 | 1 | 0 |
| Hubert Segain | 25.8 | 1 | 0 |
| Vistra | 25.8 | 1 | 0 |
| World Bank | 22.6 | 0 | 2 |
| regulatory compliance | 22.6 | 0 | 2 |
| Bank of North Dakota | 22.6 | 0 | 2 |
| Legal Services Corporation | 22.6 | 0 | 2 |
| Disaster easily averted? – Data confidentiality and the hospital desktop computer | 22.6 | 0 | 2 |
| controlled environment | 22.6 | 0 | 2 |
| Jones Walker | 22.6 | 0 | 2 |
| Q136232215 | 22.6 | 0 | 2 |
| Welding compliance | 22.6 | 0 | 2 |
| International Monetary Fund | 14.2 | 0 | 1 |
| bank | 14.2 | 0 | 1 |
| know your customer | 14.2 | 0 | 1 |
| Kaspi Bank | 14.2 | 0 | 1 |
| savings bank | 14.2 | 0 | 1 |
| Agatha Barbara | 14.2 | 0 | 1 |
| Central American Bank for Economic Integration | 14.2 | 0 | 1 |
| letter of credit | 14.2 | 0 | 1 |
| zombie bank | 14.2 | 0 | 1 |
| Institute for Works of Religion | 14.2 | 0 | 1 |
| Kasikornbank | 14.2 | 0 | 1 |
| ATB Financial | 14.2 | 0 | 1 |
| Bank for International Settlements | 14.2 | 0 | 1 |
| acquirer | 14.2 | 0 | 1 |
| Acronis | 14.2 | 0 | 1 |
| African Central Bank | 14.2 | 0 | 1 |
| Aktivbank | 14.2 | 0 | 1 |
| PostFinance | 14.2 | 0 | 1 |
| Taiwan Stock Exchange | 14.2 | 0 | 1 |
| network emulation | 14.2 | 0 | 1 |
| Common Fund for Commodities | 14.2 | 0 | 1 |
| attorney's fee | 14.2 | 0 | 1 |
| legal expenses insurance | 14.2 | 0 | 1 |
| financial institution | 14.2 | 0 | 1 |
| Noerr | 14.2 | 0 | 1 |
| International Finance Corporation | 14.2 | 0 | 1 |
| Banque et Caisse d'Épargne de l'État | 14.2 | 0 | 1 |
| Nykredit | 14.2 | 0 | 1 |
| bank account | 14.2 | 0 | 1 |
| chain of custody | 14.2 | 0 | 1 |
| assets under management | 14.2 | 0 | 1 |
| structured investment vehicle | 14.2 | 0 | 1 |
| Investor relations | 14.2 | 0 | 1 |
| Banco del Pacífico | 14.2 | 0 | 1 |
| Bancolombia | 14.2 | 0 | 1 |
| Bank of Saint George | 14.2 | 0 | 1 |
| Bangkok Bank | 14.2 | 0 | 1 |
| Bank of New Zealand | 14.2 | 0 | 1 |
| bank secrecy | 14.2 | 0 | 1 |
| International Development Association | 14.2 | 0 | 1 |
| quality control | 14.2 | 0 | 1 |
| Caixa | 14.2 | 0 | 1 |
| Nationwide Building Society | 14.2 | 0 | 1 |
| commercial bank | 14.2 | 0 | 1 |
| service-level agreement | 14.2 | 0 | 1 |
| shell bank | 14.2 | 0 | 1 |
| transaction log | 14.2 | 0 | 1 |
| Skandinaviska Enskilda Banken | 14.2 | 0 | 1 |
| Caixa Geral de Depósitos | 14.2 | 0 | 1 |
| Database security | 14.2 | 0 | 1 |
| cashier's check | 14.2 | 0 | 1 |
| Multilateral Investment Guarantee Agency | 14.2 | 0 | 1 |
| audit trail | 14.2 | 0 | 1 |
| Cassa Depositi e Prestiti | 14.2 | 0 | 1 |
| central counterparty clearing | 14.2 | 0 | 1 |
| waste treatment | 14.2 | 0 | 1 |
| Clonezilla | 14.2 | 0 | 1 |
| Bank of San Fernando | 14.2 | 0 | 1 |
| Compliance management system | 14.2 | 0 | 1 |
| Nordea | 14.2 | 0 | 1 |
| CLS Group | 14.2 | 0 | 1 |
| IT disaster recovery | 14.2 | 0 | 1 |
| PRINCE2 | 14.2 | 0 | 1 |
| global systemically important bank | 14.2 | 0 | 1 |
| Lloyds Banking Group | 14.2 | 0 | 1 |
| international financial institution | 14.2 | 0 | 1 |
| pension consultant | 14.2 | 0 | 1 |
| Q1407008 | 14.2 | 0 | 1 |
| financial intermediary | 14.2 | 0 | 1 |
| non-banking financial company | 14.2 | 0 | 1 |
| National Australia Bank | 14.2 | 0 | 1 |
| legal services | 14.2 | 0 | 1 |
| clearing house | 14.2 | 0 | 1 |
| security control | 14.2 | 0 | 1 |
| Monetary Financial Institution | 14.2 | 0 | 1 |
| preventative legal services | 14.2 | 0 | 1 |
| indoor ski slope | 14.2 | 0 | 1 |
| contract management | 14.2 | 0 | 1 |
| line of credit | 14.2 | 0 | 1 |
| lender of last resort | 14.2 | 0 | 1 |
| Nordic Investment Bank | 14.2 | 0 | 1 |
| conditioned transport | 14.2 | 0 | 1 |
| brokerage firm | 14.2 | 0 | 1 |
| savings and loan association | 14.2 | 0 | 1 |
| bank of issue | 14.2 | 0 | 1 |
| Legal Services Act | 14.2 | 0 | 1 |
| state bank | 14.2 | 0 | 1 |
| Reserve Bank of Malawi | 14.2 | 0 | 1 |
| confidentiality | 14.2 | 0 | 1 |
| BBVA Mexico | 14.2 | 0 | 1 |
| BackupAssist | 14.2 | 0 | 1 |
| Software Freedom Conservancy | 14.2 | 0 | 1 |
| savings bank | 14.2 | 0 | 1 |
| Caisse Centrale de la France Libre | 14.2 | 0 | 1 |
| banker's draft | 14.2 | 0 | 1 |
| Express Union | 14.2 | 0 | 1 |
| Institut d'Émission des Départements d'Outre-Mer | 14.2 | 0 | 1 |
| Bank Menatep | 14.2 | 0 | 1 |
| Mondo Rescue | 14.2 | 0 | 1 |
| PROPARCO | 14.2 | 0 | 1 |
| Riyad Bank | 14.2 | 0 | 1 |
| ABA routing transit number | 14.2 | 0 | 1 |
| credit limit | 14.2 | 0 | 1 |
| Caribbean Development Bank | 14.2 | 0 | 1 |
| Policy Governance | 14.2 | 0 | 1 |
| Al Habib Bank | 14.2 | 0 | 1 |
| National Bank of Kuwait | 14.2 | 0 | 1 |
| Bank of Liverpool | 14.2 | 0 | 1 |
| Bank of Jordan | 14.2 | 0 | 1 |
| medical privacy | 14.2 | 0 | 1 |
| Kiatnakin Phatra Bank | 14.2 | 0 | 1 |
| Islamic Bank of Thailand | 14.2 | 0 | 1 |
| Sberkassa | 14.2 | 0 | 1 |
| ANZ Amerika Samoa Bank | 14.2 | 0 | 1 |
| Access Bank Group | 14.2 | 0 | 1 |
| Access to Justice Act 1999 | 14.2 | 0 | 1 |
| African Bank Limited | 14.2 | 0 | 1 |
| African Export-Import Bank | 14.2 | 0 | 1 |
| African Investment Bank | 14.2 | 0 | 1 |
| Air Force Legal Operations Agency | 14.2 | 0 | 1 |
| air shower | 14.2 | 0 | 1 |
| Amalgamated Bank | 14.2 | 0 | 1 |
| ambulance chasing | 14.2 | 0 | 1 |
| American Savings Bank | 14.2 | 0 | 1 |
| Arkansas Legal Services Partnership | 14.2 | 0 | 1 |
| Army Legal Services Branch | 14.2 | 0 | 1 |
| Avvo | 14.2 | 0 | 1 |
| Banco Nacional de Crédito | 14.2 | 0 | 1 |
| Nossa Caixa | 14.2 | 0 | 1 |
| bank fraud | 14.2 | 0 | 1 |
| Bank of Maldives | 14.2 | 0 | 1 |
| Bank of Queensland | 14.2 | 0 | 1 |
| Bankers' bank | 14.2 | 0 | 1 |
| Belgian Bank | 14.2 | 0 | 1 |
| Bendigo Bank | 14.2 | 0 | 1 |
| Benson Commission | 14.2 | 0 | 1 |
| Bet Tzedek Legal Services – The House of Justice | 14.2 | 0 | 1 |
| Beverley Building Society | 14.2 | 0 | 1 |
| Botswana Savings Bank | 14.2 | 0 | 1 |
| Boubyan Bank | 14.2 | 0 | 1 |
| CPESC | 14.2 | 0 | 1 |
| California Lawyers for the Arts | 14.2 | 0 | 1 |
| Cambridge Building Society | 14.2 | 0 | 1 |
| Carver Savings and Loan Association | 14.2 | 0 | 1 |
| Center for Community Self-Help | 14.2 | 0 | 1 |
| Certified Funds | 14.2 | 0 | 1 |
| Chang Hwa Bank | 14.2 | 0 | 1 |
| Chicago Community Loan Fund | 14.2 | 0 | 1 |
| Citibank Thailand | 14.2 | 0 | 1 |
| Co-operative Legal Services | 14.2 | 0 | 1 |
| Commerce Bank & Trust Company | 14.2 | 0 | 1 |
| Commonwealth Credit Union | 14.2 | 0 | 1 |
| Community Legal Centre | 14.2 | 0 | 1 |
| community development financial institution | 14.2 | 0 | 1 |
| Consensus audit guidelines | 14.2 | 0 | 1 |
| Controlled Environment Agriculture Center | 14.2 | 0 | 1 |
| Coroners and Justice Act 2009 | 14.2 | 0 | 1 |
| County Bank | 14.2 | 0 | 1 |
| Courts and Legal Services Act 1990 | 14.2 | 0 | 1 |
| Cyprus Development Bank | 14.2 | 0 | 1 |
| Data confidentiality in clinical trials | 14.2 | 0 | 1 |
| David Bennett | 14.2 | 0 | 1 |
| Defense Contract Management Agency | 14.2 | 0 | 1 |
| deposit | 14.2 | 0 | 1 |
| depository institution | 14.2 | 0 | 1 |
| development bank | 14.2 | 0 | 1 |
| Disaster Recovery Personal Protection Act | 14.2 | 0 | 1 |
| Disaster draft | 14.2 | 0 | 1 |
| Disaster recovery and business continuity auditing | 14.2 | 0 | 1 |
| disaster recovery plan | 14.2 | 0 | 1 |
| Document review | 14.2 | 0 | 1 |
| Dragon Capital | 14.2 | 0 | 1 |
| EBS Building Society | 14.2 | 0 | 1 |
| Emigrant Savings Bank | 14.2 | 0 | 1 |
| Executive National Bank | 14.2 | 0 | 1 |
| Executive Order 12711 | 14.2 | 0 | 1 |
| First Citizens' Federal Credit Union | 14.2 | 0 | 1 |
| Futurice | 14.2 | 0 | 1 |
| GE Artesia Bank | 14.2 | 0 | 1 |
| Gateway Legal Services | 14.2 | 0 | 1 |
| Global Information Governance Day | 14.2 | 0 | 1 |
| GoFundMe | 14.2 | 0 | 1 |
| Good Documentation Practice | 14.2 | 0 | 1 |
| Gordon Briscoe | 14.2 | 0 | 1 |
| Guardian Bank | 14.2 | 0 | 1 |
| HSBC Continental Europe, Poland | 14.2 | 0 | 1 |
| Health network surveillance | 14.2 | 0 | 1 |
| Q5715890 | 14.2 | 0 | 1 |
| Banco Inversis | 14.2 | 0 | 1 |
| IIG Capital LLC | 14.2 | 0 | 1 |
| Indian Financial System Code | 14.2 | 0 | 1 |
| Mountains of Granada | 14.2 | 0 | 1 |
| IFCI Ltd | 14.2 | 0 | 1 |
| New Bank of Santa Fe | 14.2 | 0 | 1 |
| International Financial Institution Advisory Commission | 14.2 | 0 | 1 |
| voter-verified paper audit trail | 14.2 | 0 | 1 |
| Jim McIngvale | 14.2 | 0 | 1 |
| John G. Levi | 14.2 | 0 | 1 |
| Joint Task Force Katrina | 14.2 | 0 | 1 |
| Jordan Ahli Bank | 14.2 | 0 | 1 |
| Judge Advocate General Branch | 14.2 | 0 | 1 |
| Banco Español del Río de la Plata | 14.2 | 0 | 1 |
| Kerala State Legal Services Authority | 14.2 | 0 | 1 |
| LatinoJustice PRLDEF | 14.2 | 0 | 1 |
| Single Settlement and Information Space | 14.2 | 0 | 1 |
| LegalMatch | 14.2 | 0 | 1 |
| Legal Services Act 2007 | 14.2 | 0 | 1 |
| Legal Services Authorities | 14.2 | 0 | 1 |
| Legal Services Board | 14.2 | 0 | 1 |
| Legal Services Commission | 14.2 | 0 | 1 |
| Legal Services Complaints Commissioner | 14.2 | 0 | 1 |
| Legal Services Consultative Panel | 14.2 | 0 | 1 |
| Legal Services Ombudsman | 14.2 | 0 | 1 |
| Legal Services Research Centre | 14.2 | 0 | 1 |
| Legal Services Society | 14.2 | 0 | 1 |
| legal outsourcing | 14.2 | 0 | 1 |
| Lianne Dalziel | 14.2 | 0 | 1 |
| Q6762209 | 14.2 | 0 | 1 |
| Maryland Department of Emergency Management | 14.2 | 0 | 1 |
| entertainment law | 14.2 | 0 | 1 |
| Melton Mowbray Building Society | 14.2 | 0 | 1 |
| Michigan State University Federal Credit Union | 14.2 | 0 | 1 |
| Middlesex Savings Bank | 14.2 | 0 | 1 |
| Municipal Bank of Rosario | 14.2 | 0 | 1 |
| Creative Commons CC0 License | 14.2 | 0 | 1 |
| NBT Bank | 14.2 | 0 | 1 |
| National Commission on Financial Institution Reform, Recovery and Enforcement | 14.2 | 0 | 1 |
| National Conference on Citizenship | 14.2 | 0 | 1 |
| National Disaster Recovery Fund | 14.2 | 0 | 1 |
| National Information Governance Board for Health and Social Care | 14.2 | 0 | 1 |
| National disaster recovery framework | 14.2 | 0 | 1 |
| Newcastle Permanent Building Society | 14.2 | 0 | 1 |
| Nippon Kan Theatre | 14.2 | 0 | 1 |
| North American Development Bank | 14.2 | 0 | 1 |
| Northeast Bank | 14.2 | 0 | 1 |
| Nuisance abatement | 14.2 | 0 | 1 |
| One Nevada Credit Union | 14.2 | 0 | 1 |
| Pakistan Industrial Credit and Investment Corporation | 14.2 | 0 | 1 |
| Park Sterling Bank | 14.2 | 0 | 1 |
| Penrith Building Society | 14.2 | 0 | 1 |
| PostBank Uganda | 14.2 | 0 | 1 |
| Progressive Building Society | 14.2 | 0 | 1 |
| proof of funds | 14.2 | 0 | 1 |
| RAF Legal Branch | 14.2 | 0 | 1 |
| Rajasthan Financial Corporation | 14.2 | 0 | 1 |
| Raphaels Bank | 14.2 | 0 | 1 |
| Redo Backup and Recovery | 14.2 | 0 | 1 |
| Scottish Legal Services Ombudsman | 14.2 | 0 | 1 |
| Seven tiers of disaster recovery | 14.2 | 0 | 1 |
| Spring Garden National Bank | 14.2 | 0 | 1 |
| Starr-Bowkett Society | 14.2 | 0 | 1 |
| Suspicious activity report | 14.2 | 0 | 1 |
| Trustee Savings Bank | 14.2 | 0 | 1 |
| Uganda Development Bank | 14.2 | 0 | 1 |
| Unbundled legal services | 14.2 | 0 | 1 |
| Union Dime Savings Bank | 14.2 | 0 | 1 |
| virtual security switch | 14.2 | 0 | 1 |
| Westchester Interfaith/Interagency Network for Disaster and Emergency Recovery | 14.2 | 0 | 1 |
| Western Savings and Loan | 14.2 | 0 | 1 |
| Wing On Bank | 14.2 | 0 | 1 |
| World Financial Group | 14.2 | 0 | 1 |
| Xceed Financial Credit Union | 14.2 | 0 | 1 |
| Young Americans Bank | 14.2 | 0 | 1 |
| trust company | 14.2 | 0 | 1 |
| stored-value card | 14.2 | 0 | 1 |
| Category:Regulatory compliance | 14.2 | 0 | 1 |
| Bahia State Development Agency | 14.2 | 0 | 1 |
| Caixa Econômica Estadual do Rio Grande do Sul | 14.2 | 0 | 1 |
| Intervozes | 14.2 | 0 | 1 |
| credit market company | 14.2 | 0 | 1 |
| Hangzhou Municipal People’s Government | 14.2 | 0 | 1 |
| Inspector General's Office of Legal Compliance | 14.2 | 0 | 1 |
| Renta 4 Banco | 14.2 | 0 | 1 |
| Q11325503 | 14.2 | 0 | 1 |
| Shoko Chukin Bank | 14.2 | 0 | 1 |
| Act on the Handling of Legal Services by Foreign Lawyers | 14.2 | 0 | 1 |
| defense in depth | 14.2 | 0 | 1 |
| UTokyo Student Legal Services | 14.2 | 0 | 1 |
| disaster recovery | 14.2 | 0 | 1 |
| Taula de canvi | 14.2 | 0 | 1 |
| Q11722998 | 14.2 | 0 | 1 |
| EVO Banco | 14.2 | 0 | 1 |
| spray booth | 14.2 | 0 | 1 |
| Royal Chamber | 14.2 | 0 | 1 |
| Bangkok Metropolitan Bank | 14.2 | 0 | 1 |
| Thai Credit Bank | 14.2 | 0 | 1 |
| Asia Sermkij Leasing | 14.2 | 0 | 1 |
| IdeaPlane | 14.2 | 0 | 1 |
| Masking (Electronic Health Record) | 14.2 | 0 | 1 |
| Trade and Development Bank | 14.2 | 0 | 1 |
| Creative Commons Attribution-ShareAlike 3.0 Unported | 14.2 | 0 | 1 |
| Creative Commons Attribution 3.0 Unported | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | 14.2 | 0 | 1 |
| Legal Aid Agency | 14.2 | 0 | 1 |
| Consejería Jurídica y de Servicios Legales de la Ciudad de México | 14.2 | 0 | 1 |
| legal malpractice | 14.2 | 0 | 1 |
| Category:Legal Services Corporation | 14.2 | 0 | 1 |
| Industrial Bank of Kuwait | 14.2 | 0 | 1 |
| Gujarat State Financial Corporation | 14.2 | 0 | 1 |
| Highlands Union Bank | 14.2 | 0 | 1 |
| Originating Depository Financial Institution | 14.2 | 0 | 1 |
| Skipton Building Society | 14.2 | 0 | 1 |
| controlled-environment agriculture | 14.2 | 0 | 1 |
| Staten Island Legal Services | 14.2 | 0 | 1 |
| Legal Services Corp. v. Velazquez | 14.2 | 0 | 1 |
| Ecology Building Society | 14.2 | 0 | 1 |
| Legal Aid, Sentencing and Punishment of Offenders Act 2012 | 14.2 | 0 | 1 |
| Legal services in the United Kingdom | 14.2 | 0 | 1 |
| Aboriginal Legal Service of Western Australia | 14.2 | 0 | 1 |
| BLC bank | 14.2 | 0 | 1 |
| Legal Services NYC | 14.2 | 0 | 1 |
| Microjustice | 14.2 | 0 | 1 |
| Cede and Company | 14.2 | 0 | 1 |
| information governance | 14.2 | 0 | 1 |
| California Innocence Project | 14.2 | 0 | 1 |
| AirHelp | 14.2 | 0 | 1 |
| Mercantile Credit Bank | 14.2 | 0 | 1 |
| recovery as a service | 14.2 | 0 | 1 |
| David Tune | 14.2 | 0 | 1 |
| Dutch financial institution ING takes impairment charge | 14.2 | 0 | 1 |
| Asian Infrastructure Investment Bank | 14.2 | 0 | 1 |
| National Legal Services Authority v. Union of India | 14.2 | 0 | 1 |
| NRB Bank | 14.2 | 0 | 1 |
| Creative Commons Attribution-ShareAlike 4.0 International | 14.2 | 0 | 1 |
| Southern Bancorp | 14.2 | 0 | 1 |
| public interest law | 14.2 | 0 | 1 |
| Mission Federal Credit Union | 14.2 | 0 | 1 |
| Qatar Islamic Bank | 14.2 | 0 | 1 |
| Urban Justice Center | 14.2 | 0 | 1 |
| Investment Corporation of Bangladesh | 14.2 | 0 | 1 |
| Haryana State Legal Services Authority, Haryana | 14.2 | 0 | 1 |
| Caixa de Amortização | 14.2 | 0 | 1 |
| ISO 19600 | 14.2 | 0 | 1 |
| Creative Commons Attribution 3.0 United States | 14.2 | 0 | 1 |
| Creative Commons Attribution-NoDerivs 3.0 Unported | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial 3.0 Unported | 14.2 | 0 | 1 |
| Creative Commons Attribution 2.5 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-NoDerivs 2.5 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial-NoDerivs 2.5 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-ShareAlike 2.0 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial 2.5 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-ShareAlike 2.5 Generic | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | 14.2 | 0 | 1 |
| Creative Commons Attribution 2.0 Generic | 14.2 | 0 | 1 |
| ABii National | 14.2 | 0 | 1 |
| Aresbank | 14.2 | 0 | 1 |
| Communicourt | 14.2 | 0 | 1 |
| District Legal Services Authority, Rayagada | 14.2 | 0 | 1 |
| Bramer Banking Corporation | 14.2 | 0 | 1 |
| Altana Federal Credit Union | 14.2 | 0 | 1 |
| Bridge US | 14.2 | 0 | 1 |
| National Legal Services Authority | 14.2 | 0 | 1 |
| SSQ Financial Group | 14.2 | 0 | 1 |
| SFIL SA | 14.2 | 0 | 1 |
| Creative Commons Attribution 4.0 International | 14.2 | 0 | 1 |
| Template:Legal services in the United Kingdom | 14.2 | 0 | 1 |
| bank branch | 14.2 | 0 | 1 |
| Veeam Backup & Replication | 14.2 | 0 | 1 |
| Template:Legal Services Corporation | 14.2 | 0 | 1 |
| Legal Services Authorities Act, 1987 | 14.2 | 0 | 1 |
| Clara Lionel Foundation | 14.2 | 0 | 1 |
| Tiny Banker Trojan | 14.2 | 0 | 1 |
| Controlled environment for trace metal experiments on animals | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | 14.2 | 0 | 1 |
| Women's Legal Services NSW | 14.2 | 0 | 1 |
| National Contract Management Association | 14.2 | 0 | 1 |
| Amortisatiesyndicaat | 14.2 | 0 | 1 |
| Randomized controlled trial of an internet-based intervention using random-digit-dial recruitment: the Disaster Recovery Web project | 14.2 | 0 | 1 |
| Punjab Legal Services Authority | 14.2 | 0 | 1 |
| Hero FinCorp | 14.2 | 0 | 1 |
| China Renaissance | 14.2 | 0 | 1 |
| Certificate of public convenience and necessity | 14.2 | 0 | 1 |
| Chief information governance officer | 14.2 | 0 | 1 |
| Commercial Bank of Africa | 14.2 | 0 | 1 |
| OakNorth Bank | 14.2 | 0 | 1 |
| Contract management software | 14.2 | 0 | 1 |
| Creative Commons Attribution 3.0 IGO | 14.2 | 0 | 1 |
| Hazardous waste abatement. Simulation in three controlled environments | 14.2 | 0 | 1 |
| Health hazard evaluation report: HETA-82-210-1418, Legal Services Plan - DC 37, New York, New York | 14.2 | 0 | 1 |
| Domestic secondary lead industry: production and regulatory compliance costs | 14.2 | 0 | 1 |
| An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins | 14.2 | 0 | 1 |
| ISO/IEC 7942-3:1999: Information technology—Computer graphics and image processing—Graphical Kernel System (GKS)—Part 3: Audit trail | 14.2 | 0 | 1 |
| Creative Commons Sampling Plus 1.0 | 14.2 | 0 | 1 |
| Bank of the South | 14.2 | 0 | 1 |
| Merchants Bank | 14.2 | 0 | 1 |
| Fidelity Bank | 14.2 | 0 | 1 |
| Mutual Bank | 14.2 | 0 | 1 |
| Union State Bank | 14.2 | 0 | 1 |
| Heartland Bank | 14.2 | 0 | 1 |
| Law Reform (Miscellaneous Provisions) (Scotland) Act 1990 | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial-ShareAlike 2.0 Generic | 14.2 | 0 | 1 |
| Critical parameters in targeted drug development: the pharmacological audit trail | 14.2 | 0 | 1 |
| independent ATM deployer | 14.2 | 0 | 1 |
| access to justice | 14.2 | 0 | 1 |
| Georgia Legal Services Program | 14.2 | 0 | 1 |
| Chain of Custody | 14.2 | 0 | 1 |
| Reactions of a balloon crew in a controlled environment | 14.2 | 0 | 1 |
| Bangladesh House Building Finance Corporation | 14.2 | 0 | 1 |
| Birth Outcomes in a Disaster Recovery Environment: New Orleans Women After Katrina | 14.2 | 0 | 1 |
| Using software agents to preserve individual health data confidentiality in micro-scale geographical analyses | 14.2 | 0 | 1 |
| Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disaster | 14.2 | 0 | 1 |
| Translating biomonitoring data into risk management and policy implementation options for a European Network on Human Biomonitoring | 14.2 | 0 | 1 |
| A training intervention for supervisors to support a work-life policy implementation | 14.2 | 0 | 1 |
| Letshego Financial Services Botswana | 14.2 | 0 | 1 |
| Online Compliance Consortium | 14.2 | 0 | 1 |
| Green bank | 14.2 | 0 | 1 |
| 'Pop-Up' Governance: developing internal governance frameworks for consortia: the example of UK10K | 14.2 | 0 | 1 |
| Category:Information governance | 14.2 | 0 | 1 |
| Assessment of Geographic Information Systems and Data Confidentiality Guidelines in STD Programs | 14.2 | 0 | 1 |
| Information Governance as a Force for Good? Lessons to be Learnt from Care.data | 14.2 | 0 | 1 |
| Program officials' contract management course | 14.2 | 0 | 1 |
| Workplace violence and hospital security programs: regulatory compliance, program benchmarks, innovative strategies | 14.2 | 0 | 1 |
| Evaluating aggressiveness and host range of Alternaria dauci in a controlled environment | 14.2 | 0 | 1 |
| Access Credit Union | 14.2 | 0 | 1 |
| Category:Disaster recovery | 14.2 | 0 | 1 |
| Efficacy of insurance for organisational disaster recovery: case study of the 2010 and 2011 Canterbury earthquakes. | 14.2 | 0 | 1 |
| Disaster Management: Vulnerability and Resilience in Disaster Recovery in Thailand | 14.2 | 0 | 1 |
| World Marrow Donor Association Crisis Response, Business Continuity, and Disaster Recovery Guidelines | 14.2 | 0 | 1 |
| Measuring individual disaster recovery: a socioecological framework. | 14.2 | 0 | 1 |
| Analysis of Free Legal Counselling for the Great East Japan Earthquake and the Outlook for the Field of Disaster Recovery and Revitalization Law | 14.2 | 0 | 1 |
| Doctors of the World USA | 14.2 | 0 | 1 |
| Columbia Legal Services | 14.2 | 0 | 1 |
| Measurable Outcomes After Transfer From Pediatric to Adult Providers in Youth With Chronic Illness | 14.2 | 0 | 1 |
| Operational resilience: concepts, design and analysis | 14.2 | 0 | 1 |
| Maine Molecular Quality Controls (United States) | 14.2 | 0 | 1 |
| Asylum Access | 14.2 | 0 | 1 |
| Institute of Finance Management | 14.2 | 0 | 1 |
| Neighborhood Legal Services | 14.2 | 0 | 1 |
| University Legal Services | 14.2 | 0 | 1 |
| Primary healthcare policy implementation in South Asia | 14.2 | 0 | 1 |
| Cell substrates for the production of viral vaccines | 14.2 | 0 | 1 |
| Sensitive probes of protein structure and dynamics in well-controlled environments: combining mass spectrometry with fluorescence spectroscopy | 14.2 | 0 | 1 |
| Regulatory compliance for point-of-care testing: 2009 United States perspective | 14.2 | 0 | 1 |
| Explaining differences in stakeholder take up of disease management programmes: A comparative analysis of policy implementation in Austria and Germany | 14.2 | 0 | 1 |
| Policy implementation of methadone maintenance treatment and HIV infection: evidence from Hubei province, China | 14.2 | 0 | 1 |
| A rapid equity focused health impact assessment of a policy implementation plan: An Australian case study and impact evaluation | 14.2 | 0 | 1 |
| Initiatives and experiences in developing, implementing, and administering data security and confidentiality policies. | 14.2 | 0 | 1 |
| Contract management: hospitals need comparative data to keep ahead of new regulations | 14.2 | 0 | 1 |
| Patient data: fueling your disease management program with targeted interventions and measurable outcomes | 14.2 | 0 | 1 |
| Using external data sources to improve audit trail analysis | 14.2 | 0 | 1 |
| Backup and Disaster Recovery appliance | 14.2 | 0 | 1 |
| Data confidentiality. Drug habits in the dock. | 14.2 | 0 | 1 |
| Palli Karma Sahayak Foundation | 14.2 | 0 | 1 |
| An Examination of Data Confidentiality and Disclosure Issues Related to Publication of Empirical ROC Curves | 14.2 | 0 | 1 |
| Patient data confidentiality and patient rights | 14.2 | 0 | 1 |
| Effect of climate change on Alternaria leaf spot of rocket salad and black spot of basil under controlled environment | 14.2 | 0 | 1 |
| Information governance. The price of data sharing | 14.2 | 0 | 1 |
| Texas Legal Services Center | 14.2 | 0 | 1 |
| Keeping information clean. New information governance efforts challenge him to sort out dirty data | 14.2 | 0 | 1 |
| Governance apples and oranges. Differences exist between information governance, data governance, and IT governance | 14.2 | 0 | 1 |
| [The study of social economic factors which influence the fertility of the eligible couples for population policy implementation: a case study in Ujung Pandang]. | 14.2 | 0 | 1 |
| "Proof of concept" pilot study: bioprocess chain of custody and bioresource sample management temperature observations. Sample level temperature trends and stability data obtained via utilization of bluechiip(®) temperature tracking technology | 14.2 | 0 | 1 |
| FDA considers data confidentiality for diabetes drugs | 14.2 | 0 | 1 |
| An integrated organisation-wide data quality management and information governance framework: theoretical underpinnings | 14.2 | 0 | 1 |
| Society of Toxicologic Pathology position on histopathology data collection and audit trail: compliance with 21 CFR parts 58 and 11. | 14.2 | 0 | 1 |
| Computer-based data collection boosts productivity, regulatory compliance. | 14.2 | 0 | 1 |
| The way forward. AIHMA develops information governance principles to lead healthcare toward better data management | 14.2 | 0 | 1 |
| A new method for on-line measurement of diurnal change in potato tuber growth under controlled environments | 14.2 | 0 | 1 |
| Assessing Subject Privacy and Data Confidentiality in an Emerging Region for Clinical Trials: United Arab Emirates | 14.2 | 0 | 1 |
| Creative Commons Attribution 1.0 Generic | 14.2 | 0 | 1 |
| Operational resilience of reservoirs to climate change, agricultural demand, and tourism: A case study from Sardinia. | 14.2 | 0 | 1 |
| Disaster recovery for electronic data: are you prepared? | 14.2 | 0 | 1 |
| New controlled environment vitrification system for cryo-transmission electron microscopy: design and application to surfactant solutions | 14.2 | 0 | 1 |
| Effect of temperature, elevated carbon dioxide, and drought during seed development on the isoflavone content of dwarf soybean [Glycine max (L.) Merrill] grown in controlled environments | 14.2 | 0 | 1 |
| Maintaining high-volume, low-pressure surface-coating regulatory compliance using the U.s. Environmental Protection Agency's data quality objectives process | 14.2 | 0 | 1 |
| Methodological issues in a multicentric study of gastric cancer and diet in Italy: study design, data sources and quality controls. | 14.2 | 0 | 1 |
| Lipid membrane phase behaviour elucidated in real time by controlled environment atomic force microscopy | 14.2 | 0 | 1 |
| Electronic patient data confidentiality practices among surgical trainees: questionnaire study | 14.2 | 0 | 1 |
| Detritus quality controls macrophyte decomposition under different nutrient concentrations in a eutrophic shallow lake, North China | 14.2 | 0 | 1 |
| INFORMATION GOVERNANCE FOR OFFSITE DATA SECURITY. | 14.2 | 0 | 1 |
| Urgent need for normalization of corneal graft quality controls in French eye banks | 14.2 | 0 | 1 |
| German-Dutch Finance Agreement (Tredefina) | 14.2 | 0 | 1 |
| Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. | 14.2 | 0 | 1 |
| Controlled environment transmission electron microscopy | 14.2 | 0 | 1 |
| Facsimile communication between emergency departments and GPs, and patient data confidentiality | 14.2 | 0 | 1 |
| Q32625225 | 14.2 | 0 | 1 |
| bank manager | 14.2 | 0 | 1 |
| Simulation of disaster recovery of a picture archiving and communications system using off-site hierarchal storage management | 14.2 | 0 | 1 |
| Two-dimensional gap analysis: a tool for efficient conservation planning and biodiversity policy implementation | 14.2 | 0 | 1 |
| Wireless remote control of clinical image workflow: using a PDA for off-site distribution and disaster recovery | 14.2 | 0 | 1 |
| Training for disaster recovery: a review of training programs for social workers after the tsunami | 14.2 | 0 | 1 |
| Short-term genome evolution of Listeria monocytogenes in a non-controlled environment | 14.2 | 0 | 1 |
| Evaporation of sessile water/ethanol drops in a controlled environment | 14.2 | 0 | 1 |
| Data confidentiality and data handling in research: a workshop report. | 14.2 | 0 | 1 |
| Producer nutritional quality controls ecosystem trophic structure | 14.2 | 0 | 1 |
| Analysis of neem oils by LC-MS and degradation kinetics of azadirachtin-A in a controlled environment. Characterization of degradation products by HPLC-MS-MS. | 14.2 | 0 | 1 |
| Computer security and data confidentiality | 14.2 | 0 | 1 |
| Organic acid production in vitro and plant growth promotion in maize under controlled environment by phosphate-solubilizing fluorescent Pseudomonas | 14.2 | 0 | 1 |
| A review of the UK methodology used for monitoring cigarette smoke yields, aspects of analytical data variability and their impact on current and future regulatory compliance | 14.2 | 0 | 1 |
| Tobacco control environment: cross-sectional survey of policy implementation, social unacceptability, knowledge of tobacco health harms and relationship to quit ratio in 17 low-income, middle-income and high-income countries | 14.2 | 0 | 1 |
| Conducting a managed care contract review | 14.2 | 0 | 1 |
| What is the importance of due-diligence in managed care contract review? | 14.2 | 0 | 1 |
| Contract management: does grafting this hospital concept onto group practice work? | 14.2 | 0 | 1 |
| Rapid and conformal coating of polymer resins by airbrushing for continuous and high-speed roll-to-roll nanopatterning: parametric quality controls and extended applications | 14.2 | 0 | 1 |
| Organizational issues in U.S. health policy implementation: participation, discretion, and accountability. | 14.2 | 0 | 1 |
| A legal services perspectives on representing Medicare home health patients | 14.2 | 0 | 1 |
| Are functional foods the solution to dysfunctional diets? A review of U.S. regulatory requirements and lessons from abroad. | 14.2 | 0 | 1 |
| Electronic fetal monitoring. Are we meeting documentation standards? | 14.2 | 0 | 1 |
| Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects | 14.2 | 0 | 1 |
| Regulatory requirements for biocides on the market in the European Union according to Directive 98/8/EC. | 14.2 | 0 | 1 |
| A resource-dependence model of hospital contract management | 14.2 | 0 | 1 |
| Hospital contract management. Organizational and public policy issues | 14.2 | 0 | 1 |
| Hospital contract management: a descriptive profile | 14.2 | 0 | 1 |
| Effects of contract management on hospital performance | 14.2 | 0 | 1 |
| Compliance with vessel speed restrictions to protect North Atlantic right whales | 14.2 | 0 | 1 |
| Instrumental and bio-monitoring of heavy metal and nanoparticle emissions from diesel engine exhaust in controlled environment | 14.2 | 0 | 1 |
| Global implementation of advanced urological care: Policy implementation research | 14.2 | 0 | 1 |
| Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S | 14.2 | 0 | 1 |
| Pathology archive: evaluation of integrity, regulatory compliance, and construction of searchable database from print reports. | 14.2 | 0 | 1 |
| Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design | 14.2 | 0 | 1 |
| The “Ins” and “Outs” of Physical Activity Policy Implementation: Inadequate Capacity, Inappropriate Outcome Measures, and Insufficient Funds | 14.2 | 0 | 1 |
| Optimizing revenues through effective contract management. | 14.2 | 0 | 1 |
| Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail | 14.2 | 0 | 1 |
| Family Influences on the Long Term Post-Disaster Recovery of Puerto Rican Youth | 14.2 | 0 | 1 |
| Creative Commons Attribution-NonCommercial 4.0 International | 14.2 | 0 | 1 |
| Individual and collective responsibility to enhance regulatory compliance of the Three Rs | 14.2 | 0 | 1 |
| WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys | 14.2 | 0 | 1 |
| Recent developments in regulatory requirements for developmental toxicology | 14.2 | 0 | 1 |
| Don't roll the dice on data loss. Implement smart recovery to reduce disaster recovery costs in healthcare | 14.2 | 0 | 1 |
| Improving disaster recovery outcomes. Healthcare data ust be protected to conform to HIPAA requirements, which active archive supports through the expanded role of tape | 14.2 | 0 | 1 |
| Biocide rotation in the healthcare setting: is there a case for policy implementation? | 14.2 | 0 | 1 |
| Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols | 14.2 | 0 | 1 |
| Avoidance of Phycomyces in a controlled environment | 14.2 | 0 | 1 |
| Best practices in healthcare disaster recovery planning: The push to adopt EHRs is creating new data management challenges for healthcare IT executives. | 14.2 | 0 | 1 |
| Antiparasitic drugs: availability and regulatory requirements for "emergency" supply. | 14.2 | 0 | 1 |
| Effect of climate change on infection of grapevine by downy and powdery mildew under controlled environment | 14.2 | 0 | 1 |
| Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling | 14.2 | 0 | 1 |
| Contract management. Consultants, software help maximize payments. | 14.2 | 0 | 1 |
| Measures to ensure data confidentiality in Clinical Units in order to achieve quality accreditation in Andalusia | 14.2 | 0 | 1 |
| Quantitatively monitoring AIDS policy implementation in China | 14.2 | 0 | 1 |
| China AIDS policy implementation: reversing the HIV/AIDS epidemic by 2015 | 14.2 | 0 | 1 |
| Plant productivity in controlled environments | 14.2 | 0 | 1 |
| Regulatory requirements for designing PET-CT facility in India | 14.2 | 0 | 1 |
| Enantiomeric drug development: Issues, considerations, and regulatory requirements | 14.2 | 0 | 1 |
| School and Community Influences on the Long Term Post-Disaster Recovery of Children and Youth Following Hurricane Georges | 14.2 | 0 | 1 |
| Guidelines to use tomato in experiments with a controlled environment | 14.2 | 0 | 1 |
| Prioritizing congenital syphilis control in south China: a decision analytic model to inform policy implementation | 14.2 | 0 | 1 |
| Housing Reconstruction in Disaster Recovery: A Study of Fishing Communities Post-Tsunami in Chennai, India | 14.2 | 0 | 1 |
| Regulatory requirements and tools for environmental assessment of hazardous wastes: understanding tribal and stakeholder concerns using Department of Energy sites | 14.2 | 0 | 1 |
| Healthy start: description of a safety net for perinatal support during disaster recovery. | 14.2 | 0 | 1 |
| Internationalization of regulatory requirements | 14.2 | 0 | 1 |
| Validating Indicators of Disaster Recovery with Qualitative Research | 14.2 | 0 | 1 |
| A novel facility for 3D micro-irradiation of living cells in a controlled environment by MeV ions | 14.2 | 0 | 1 |
| A quality improvement programme to increase compliance with an anti-infective prescribing policy. | 14.2 | 0 | 1 |
| Revenue recovery on a grand scale. Rhode Island healthcare system uses contract management technology and services to recover unpaid millions. | 14.2 | 0 | 1 |
| Development and implementation of a dedicated postoperative evaluation service to improve compliance of postoperative visits | 14.2 | 0 | 1 |
| Controlled environment specimen transfer | 14.2 | 0 | 1 |
| Exploring the audit trail for qualitative investigations | 14.2 | 0 | 1 |
| The impact of escalating regulatory requirements on the conduct of clinical research | 14.2 | 0 | 1 |
| Creative Commons Attribution-NoDerivs 2.0 Generic | 14.2 | 0 | 1 |
| Interacting microbe and litter quality controls on litter decomposition: a modeling analysis | 14.2 | 0 | 1 |
| One-month comparative efficacy of three topical ectoparasiticides against adult brown dog ticks (Rhipicephalus sanguineus sensu lato) on mixed-bred dogs in controlled environment | 14.2 | 0 | 1 |
| Municipal bylaw to reduce cosmetic/non-essential pesticide use on household lawns - a policy implementation evaluation. | 14.2 | 0 | 1 |
| Understanding FDA regulatory requirements for investigational new drug applications for sponsor-investigators | 14.2 | 0 | 1 |
| Assisting Australians with mental health problems and financial difficulties: a Delphi study to develop guidelines for financial counsellors, financial institution staff, mental health professionals and carers | 14.2 | 0 | 1 |
| Promoter-Autonomous Functioning in a Controlled Environment using Single Molecule FISH. | 14.2 | 0 | 1 |
| An Assessment of Nutrition Practices and Attitudes in Family Child-Care Homes: Implications for Policy Implementation | 14.2 | 0 | 1 |
| The practice and regulatory requirements of naturopathy and western herbal medicine in Australia | 14.2 | 0 | 1 |
| Quality controls | 14.2 | 0 | 1 |
| Spatial video geonarratives and health: case studies in post-disaster recovery, crime, mosquito control and tuberculosis in the homeless | 14.2 | 0 | 1 |
| User experience with a health insurance coverage and benefit-package access: implications for policy implementation towards expansion in Nigeria | 14.2 | 0 | 1 |
| Reversing the trend of weak policy implementation in the Kenyan health sector?--a study of budget allocation and spending of health resources versus set priorities | 14.2 | 0 | 1 |
| Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment | 14.2 | 0 | 1 |
| Prevalence of obesity and overweight and associated factors among financial institution workers in Accra Metropolis, Ghana: a cross sectional study | 14.2 | 0 | 1 |
| My Disaster Recovery: a pilot randomized controlled trial of an Internet intervention | 14.2 | 0 | 1 |
| Laboratory information management system chain of custody: reliability and security | 14.2 | 0 | 1 |
| Risk management and disaster recovery planning for online libraries | 14.2 | 0 | 1 |
| Assessing the daily stability of the cortisol awakening response in a controlled environment. | 14.2 | 0 | 1 |
| Policy implementation in practice: the case of national service frameworks in general practice. | 14.2 | 0 | 1 |
| Regulatory compliance requirements for an open source electronic image trial management system | 14.2 | 0 | 1 |
| A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment. | 14.2 | 0 | 1 |
| Agreement between 24-hour salt ingestion and sodium excretion in a controlled environment | 14.2 | 0 | 1 |
| Driving to contract management in health care institutes of developing countries. | 14.2 | 0 | 1 |
| Researching income and income distribution as determinants of health in Canada: gaps between theoretical knowledge, research practice, and policy implementation | 14.2 | 0 | 1 |
| Evaluation of Daily Physical Activity (DPA) policy implementation in Ontario: surveys of elementary school administrators and teachers | 14.2 | 0 | 1 |
| Combining field performance with controlled environment plant imaging to identify the genetic control of growth and transpiration underlying yield response to water-deficit stress in wheat. | 14.2 | 0 | 1 |
| Progress towards the elimination of leprosy in Nigeria: a review of the role of policy implementation and operational factors | 14.2 | 0 | 1 |
| Documentation standards set by the Clinical Negligence Scheme for Trusts | 14.2 | 0 | 1 |
| Prevalence and predictors of smoke-free policy implementation and support among owners and managers of multiunit housing | 14.2 | 0 | 1 |
| Responsible conduct of radiology research: part II. Regulatory requirements for human research | 14.2 | 0 | 1 |
| Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators | 14.2 | 0 | 1 |
| Dietary recommendations for cancer prevention: public policy implementation | 14.2 | 0 | 1 |
| Responsible conduct of radiology research. Part III. Exemptions from regulatory requirements for human research | 14.2 | 0 | 1 |
| Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa | 14.2 | 0 | 1 |
| Information governance standards for managing e-health information | 14.2 | 0 | 1 |
| Myths and realities about the recovery of L׳Aquila after the earthquake | 14.2 | 0 | 1 |
| Reformulation of Traditional Chamomile Oil: Quality Controls and Fingerprint Presentation Based on Cluster Analysis of Attenuated Total Reflectance-Infrared Spectral Data | 14.2 | 0 | 1 |
| Studying policy implementation using a macro, meso and micro frame analysis: the case of the Collaboration for Leadership in Applied Health Research & Care (CLAHRC) programme nationally and in North West London | 14.2 | 0 | 1 |
| Businesses push the limits of data confidentiality | 14.2 | 0 | 1 |
| A comprehensive study on regulatory requirements for development and filing of generic drugs globally | 14.2 | 0 | 1 |
| Security practices and regulatory compliance in the healthcare industry | 14.2 | 0 | 1 |
| Policy implementation and financial incentives for nurses in South Africa: a case study on the occupation-specific dispensation | 14.2 | 0 | 1 |
| cis regulatory requirements for hypodermal cell-specific expression of the Caenorhabditis elegans cuticle collagen gene dpy-7. | 14.2 | 0 | 1 |
| Participatory workshops are not enough to prevent policy implementation failures: an example of a policy development process concerning the drug interferon-beta for multiple sclerosis | 14.2 | 0 | 1 |
| How hard can it be to include research evidence and evaluation in local health policy implementation? Results from a mixed methods study | 14.2 | 0 | 1 |
| Information governance in NHS's NPfIT: a case for policy specification | 14.2 | 0 | 1 |
| Chain of custody as an organizing framework in seafood risk reduction | 14.2 | 0 | 1 |
| Measurable outcomes in psychiatric disorders: remission as a marker of wellness | 14.2 | 0 | 1 |
| Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements. | 14.2 | 0 | 1 |
| Health system capacity: maternal health policy implementation in the state of Gujarat, India | 14.2 | 0 | 1 |
| Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys | 14.2 | 0 | 1 |
| Determination of total trans fats and oils by infrared spectroscopy for regulatory compliance | 14.2 | 0 | 1 |
| Creative Commons Attribution-NoDerivs 4.0 International | 14.2 | 0 | 1 |
| Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays | 14.2 | 0 | 1 |
| Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples | 14.2 | 0 | 1 |
| Regulatory compliance in solid-organ transplantation: what you don't know can hurt your program | 14.2 | 0 | 1 |
| Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls | 14.2 | 0 | 1 |
| Understanding the dynamics of the Seguro Popular de Salud policy implementation in Mexico from a complex adaptive systems perspective | 14.2 | 0 | 1 |
| Recasting Disaster Recovery Strategy at Dental Workplace in Combating Crisis - A Questionnaire Study | 14.2 | 0 | 1 |
| Never the twain shall meet? - a comparison of implementation science and policy implementation research | 14.2 | 0 | 1 |
| Regulatory requirements for vaccine authorisation | 14.2 | 0 | 1 |
| International harmonisation of regulatory requirements. | 14.2 | 0 | 1 |
| Food sales outlets, food availability, and the extent of nutrition policy implementation in schools in British Columbia. | 14.2 | 0 | 1 |
| Addressing antimicrobial resistance in China: policy implementation in a complex context | 14.2 | 0 | 1 |
| Governance, health policy implementation and the added value of regionalization. | 14.2 | 0 | 1 |
| IT disaster recovery: are you prepared? | 14.2 | 0 | 1 |
| Strategies to overcome physician shortages in northern Ontario: a study of policy implementation over 35 years | 14.2 | 0 | 1 |
| Shaping legal abortion provision in Ghana: using policy theory to understand provider-related obstacles to policy implementation | 14.2 | 0 | 1 |
| Internal audits: setting the stage for Joint Commission surveys. | 14.2 | 0 | 1 |
| USDA Snack Policy Implementation: Best Practices From the Front Lines, United States, 2013-2014. | 14.2 | 0 | 1 |
| Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy. | 14.2 | 0 | 1 |
| Regulatory Requirements for Staphylococcus aureus Nitric Oxide Resistance | 14.2 | 0 | 1 |
| Follow-Up of External Quality Controls for PCR-Based Diagnosis of Whooping Cough in a Hospital Laboratory Network (Renacoq) and in Other Hospital and Private Laboratories in France | 14.2 | 0 | 1 |
| Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000. | 14.2 | 0 | 1 |
| Regulatory compliance in the dental office | 14.2 | 0 | 1 |
| Speed versus accuracy in decision-making ants: expediting politics and policy implementation | 14.2 | 0 | 1 |
| Strength and comprehensiveness of district school wellness policies predict policy implementation at the school level | 14.2 | 0 | 1 |
| Rights and duties policy implementation in Chile: health-care professionals' perceptions. | 14.2 | 0 | 1 |
| Ubiquitin-dependent and -independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases | 14.2 | 0 | 1 |
| Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered | 14.2 | 0 | 1 |
| Tobacco smoke exposure in public places and workplaces after smoke-free policy implementation: a longitudinal analysis of smoker cohorts in Mexico and Uruguay | 14.2 | 0 | 1 |
| Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN) | 14.2 | 0 | 1 |
| Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment | 14.2 | 0 | 1 |
| Trans fat labeling and levels in U.S. foods: assessment of gas chromatographic and infrared spectroscopic techniques for regulatory compliance | 14.2 | 0 | 1 |
| Infection control and hazards management. Economics of regulatory compliance | 14.2 | 0 | 1 |
| Jezebel at the welfare office: How racialized stereotypes of poor women's reproductive decisions and relationships shape policy implementation. | 14.2 | 0 | 1 |
| Regulatory requirements for clinical trials in India: What academicians need to know | 14.2 | 0 | 1 |
| HIV policy implementation in two health and demographic surveillance sites in Uganda: findings from a national policy review, health facility surveys and key informant interviews | 14.2 | 0 | 1 |
| Soil quality assessment under emerging regulatory requirements | 14.2 | 0 | 1 |
| Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines | 14.2 | 0 | 1 |
| Overall impact of the regulatory requirements for genotoxic impurities on the drug development process | 14.2 | 0 | 1 |
| Legal services: best, promising, and emerging practices | 14.2 | 0 | 1 |
| Social and ethical issues in environmental remediation projects | 14.2 | 0 | 1 |
| Regulatory requirements for clinical evaluation of antimicrobial agents | 14.2 | 0 | 1 |
| Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? | 14.2 | 0 | 1 |
| Healthy marriage initiatives: on the need for empiricism in policy implementation. | 14.2 | 0 | 1 |
| Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs | 14.2 | 0 | 1 |
| How to reduce nephropathy following contrast-enhanced CT: A lesson in policy implementation | 14.2 | 0 | 1 |
| Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting | 14.2 | 0 | 1 |
| Removal of user fees for caesareans and under-fives in northern Sudan: a review of policy implementation and effectiveness | 14.2 | 0 | 1 |
| An overview of FDA regulatory requirements for new medical devices | 14.2 | 0 | 1 |
| Medicare Part D Research Highlights and Policy Updates, 2013: Impact and Insights | 14.2 | 0 | 1 |
| Legal Services: A Necessary Component of Patient Navigation | 14.2 | 0 | 1 |
| Safety and regulatory requirements and challenge for CNS drug development | 14.2 | 0 | 1 |
| Consensus-Oriented Group Peer Review: A New Process to Review Radiologist Work Output | 14.2 | 0 | 1 |
| Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements | 14.2 | 0 | 1 |
| 'Do Not Attempt Cardiopulmonary Resuscitation' discussions at the point of discharge: a case note review of hospice practice following local integrated policy implementation. | 14.2 | 0 | 1 |
| History of Regulatory Requirements for Poultry Biologics in the United States, 1970s to 1990s | 14.2 | 0 | 1 |
| Regulatory Requirements for PET Drug Production. | 14.2 | 0 | 1 |
| Effects of light quality on the accumulation of phytochemicals in vegetables produced in controlled environments: a review | 14.2 | 0 | 1 |
| Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning | 14.2 | 0 | 1 |
| Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: Impact on bioequivalence | 14.2 | 0 | 1 |
| A European Perspective on Orally Inhaled Products: In Vitro Requirements for a Biowaiver | 14.2 | 0 | 1 |
| Risk for Hepatitis B and C Virus Transmission in Nail Salons and Barbershops and State Regulatory Requirements to Prevent Such Transmission in the United States | 14.2 | 0 | 1 |
| The debate on animal ADME studies in drug development: an update | 14.2 | 0 | 1 |
| Mapping the existing body of health policy implementation research in lower income settings: what is covered and what are the gaps? | 14.2 | 0 | 1 |
| Practice and power: a review and interpretive synthesis focused on the exercise of discretionary power in policy implementation by front-line providers and managers | 14.2 | 0 | 1 |
| Regulatory, legislative, and policy updates with anticoagulant use. | 14.2 | 0 | 1 |
| From Leaders, For Leaders: Advice From the Lived Experience of Leaders in Community Health Sector Disaster Recovery After Hurricanes Irene and Sandy | 14.2 | 0 | 1 |
| Standard operating procedure for audio visual recording of informed consent: An initiative to facilitate regulatory compliance | 14.2 | 0 | 1 |
| Realistic nurse‐led policy implementation, optimization and evaluation: novel methodological exemplar | 14.2 | 0 | 1 |
| Disaster recovery: lessons learned from an occupational health and human resources perspective. | 14.2 | 0 | 1 |
| Security and confidentiality approach for the Clinical E-Science Framework (CLEF). | 14.2 | 0 | 1 |
| Applying new thinking from the linked and emerging fields of digital identity and privacy to information governance in health informatics. | 14.2 | 0 | 1 |
| A comparison of the results of regulatory compliance inspections in 1999 by the states of Texas, Maine, and Washington | 14.2 | 0 | 1 |
| Design and implementation of an audit trail in compliance with US regulations | 14.2 | 0 | 1 |
| Sugar Accumulation Cycle in Sugar Cane. II. Relationship of Invertase Activity to Sugar Content & Growth Rate in Storage Tissue of Plants Grown in Controlled Environments | 14.2 | 0 | 1 |
| Radiation safety program outcomes as indicated by regulatory compliance activities from 1988 to 1997 in Texas | 14.2 | 0 | 1 |
| What are the World Health Organization's strategies for meeting regulatory requirements? A case study of artesunate | 14.2 | 0 | 1 |
| Choosing plants to be grown in a Controlled Environment Life Support System (CELSS) based upon attractive vegetarian diets | 14.2 | 0 | 1 |
| Quality controls in integrative approaches to detect errors and inconsistencies in biological databases | 14.2 | 0 | 1 |
| Wheat production in controlled environments. | 14.2 | 0 | 1 |
| Current Industrial Practices and Regulatory Requirements to Assess Analyte and Reagent Stability Using Ligand-Binding Assays | 14.2 | 0 | 1 |
| The Information Governance Road Map: Mile Marker 2--Updates from the Journey | 14.2 | 0 | 1 |
| Polypill: Progress and Challenges to Global Use--Update on the Trials and Policy Implementation | 14.2 | 0 | 1 |
| Insights on the Intersection of Health Equity and School Nutrition Policy Implementation: An Exploratory Qualitative Secondary Analysis | 14.2 | 0 | 1 |
| Ethical issues of informed consent in malaria research proposals submitted to a research ethics committee in Thailand: a retrospective document review | 14.2 | 0 | 1 |
| Policy implementation for methicillin-resistant Staphylococcus aureus in seven European countries: a comparative analysis from 1999 to 2015. | 14.2 | 0 | 1 |
| Force Myography for Monitoring Grasping in Individuals with Stroke with Mild to Moderate Upper-Extremity Impairments: A Preliminary Investigation in a Controlled Environment | 14.2 | 0 | 1 |
| A 3D bioprinting exemplar of the consequences of the regulatory requirements on customized processes. | 14.2 | 0 | 1 |
| Disinfection byproduct regulatory compliance surrogates and bromide-associated risk | 14.2 | 0 | 1 |
| Implementation of Good Laboratory Practices (GLP) in basic scientific research: Translating the concept beyond regulatory compliance | 14.2 | 0 | 1 |
| MetaboQC: A tool for correcting untargeted metabolomics data with mass spectrometry detection using quality controls | 14.2 | 0 | 1 |
| Hydration forces between aligned DNA helices undergoing B to A conformational change: In-situ X-ray fiber diffraction studies in a humidity and temperature controlled environment | 14.2 | 0 | 1 |
| The Sociopolitical Context of Canada's National Standard for Psychological Health and Safety in the Workplace: Navigating Policy Implementation | 14.2 | 0 | 1 |
| Improving Safe Sleep Modeling in the Hospital through Policy Implementation. | 14.2 | 0 | 1 |
| Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps | 14.2 | 0 | 1 |
| An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements | 14.2 | 0 | 1 |
| Getting back to nature: a reality check for experiments in controlled environments | 14.2 | 0 | 1 |
| Development of biosimilars | 14.2 | 0 | 1 |
| Regulatory Compliance in Mammography | 14.2 | 0 | 1 |
| Stability Testing of Herbal Drugs: Challenges, Regulatory Compliance and Perspectives | 14.2 | 0 | 1 |
| Moving toward a paradigm shift in the regulatory requirements for pediatric medicines | 14.2 | 0 | 1 |
| Suicidality associated with PTSD, depression, and disaster recovery status among adult survivors 8 years after the 2008 Wenchuan earthquake in China | 14.2 | 0 | 1 |
| Computable Information Governance Contracts | 14.2 | 0 | 1 |
| A Lens for Evaluating Genetic Information Governance Models: Balancing Equity, Efficiency and Sustainability | 14.2 | 0 | 1 |
| UV-B effects on leaves-Oxidative stress and acclimation in controlled environments | 14.2 | 0 | 1 |
| Qualitative Assessment of a Novel Efficacy-Focused Training Intervention for Public Health Workers in Disaster Recovery | 14.2 | 0 | 1 |
| Regulatory requirements for genotoxicity assessment of plant protection product active ingredients, impurities, and metabolites | 14.2 | 0 | 1 |
| Examining Public Health Workers' Perceptions Toward Participating in Disaster Recovery After Hurricane Sandy: A Quantitative Assessment | 14.2 | 0 | 1 |
| How is your biobank handling disaster recovery efforts? | 14.2 | 0 | 1 |
| Combined effects of CO2 enrichment, diurnal light levels and water stress on foliar metabolites of potato plants grown in naturally sunlit controlled environment chambers | 14.2 | 0 | 1 |
| International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites | 14.2 | 0 | 1 |
| Effect of volume of porogens on the porosity of PLGA scaffolds in pH-controlled environment. | 14.2 | 0 | 1 |
| A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business | 14.2 | 0 | 1 |